Bicycle Therapeutics Plc (BCYC)
4.875
-0.28
(-5.34%)
USD |
NASDAQ |
May 07, 16:00
5.06
+0.18
(+3.79%)
After-Hours: 20:00
Bicycle Therapeutics Research and Development Expense (Annual) : 275.85M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.026M |
| Mereo BioPharma Group Plc | 17.81M |
| NuCana Plc | 16.79M |
| DBV Technologies SA | 107.12M |
| Cellectis SA | 75.08M |